It is currently approved to treat B cell chronic lymphocytic leukemia (CLL) in patients who have been treated with alkylating agents and who have not responded to fludarabine therapy.

• 当前它被批准用于那些曾使用过烷基化试剂治疗和那些对氟达拉滨治疗反应无效的B细胞性慢性淋巴细胞白血病患者的治疗。